Cardiovascular Diseases in Brazil: Premature Mortality, Risk Factors and Priorities for Action. Comments on the Preliminary Results from the Brazilian National Health Survey (PNS), 2013

Overview

Journal Sao Paulo Med J

Specialty General Medicine

Date 2015 May 29

PMID 26018879

Citations 13

Authors

Paulo Andrade Lotufo

Affiliations

Soon will be listed here.

Citing Articles

Constructing causal pathways for premature cardiovascular disease mortality using directed acyclic graphs with integrating evidence synthesis and expert knowledge.

Hasani W, Musa K, Chen X, Cheng K Sci Rep. 2024; 14(1):28849.

PMID: 39572630 PMC: 11582656. DOI: 10.1038/s41598-024-80091-0.

Prognostic factors for premature cardiovascular disease mortality in Malaysia: a modelling approach using semi-parametric and parametric survival analysis with national health and morbidity survey linked mortality data.

Hasani W, Musa K, Omar M, Hanis T, Kueh Y, Ganapathy S BMC Public Health. 2024; 24(1):2745.

PMID: 39379865 PMC: 11462735. DOI: 10.1186/s12889-024-20104-9.

Challenges faced by patients with dyslipidemia and systemic arterial hypertension in Brazil: a design of the patient journey.

Faria-Neto J, Yarleque C, Vieira L, Sakane E, Santos R BMC Cardiovasc Disord. 2022; 22(1):237.

PMID: 35597901 PMC: 9124411. DOI: 10.1186/s12872-022-02669-8.

Chronic inflammatory diseases, subclinical atherosclerosis, and cardiovascular diseases: Design, objectives, and baseline characteristics of a prospective case-cohort study ‒ ELSA-Brasil.

Bensenor I, Goulart A, Pereira A, Brunoni A, Alencar A, Santos R Clinics (Sao Paulo). 2022; 77:100013.

PMID: 35397368 PMC: 9006752. DOI: 10.1016/j.clinsp.2022.100013.

Changes in prevalence of cognitive impairment and associated risk factors 2000-2015 in São Paulo, Brazil.

Ribeiro F, de Oliveira Duarte Y, Santos J, Leist A BMC Geriatr. 2021; 21(1):609.

PMID: 34706666 PMC: 8554830. DOI: 10.1186/s12877-021-02542-x.

References

Eisenberg M, Filion K, Yavin D, Belisle P, Mottillo S, Joseph L . Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ. 2008; 179(2):135-44. PMC: 2443223. DOI: 10.1503/cmaj.070256. View

Torquato M, Junior R, Viana L, de Souza R, Lanna C, Lucas J . Prevalence of diabetes mellitus and impaired glucose tolerance in the urban population aged 30-69 years in Ribeirão Preto (São Paulo), Brazil. Sao Paulo Med J. 2004; 121(6):224-30. PMC: 11110637. DOI: 10.1590/s1516-31802003000600002. View

Piva e Mattos L, Berwanger O, Dos Santos E, Reis H, Romano E, Petriz J . Clinical outcomes at 30 days in the Brazilian Registry of Acute Coronary Syndromes (ACCEPT). Arq Bras Cardiol. 2013; 100(1):6-13. DOI: 10.1590/s0066-782x2013000100003. View

Goulart A, Santos I, Sitnik D, Staniak H, Fedeli L, Pastore C . Design and baseline characteristics of a coronary heart disease prospective cohort: two-year experience from the strategy of registry of acute coronary syndrome study (ERICO study). Clinics (Sao Paulo). 2013; 68(3):431-4. PMC: 3611751. DOI: 10.6061/clinics/2013(03)rc02. View

McConnachie A, Walker A, Robertson M, Marchbank L, Peacock J, Packard C . Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study. Eur Heart J. 2013; 35(5):290-8. PMC: 3909301. DOI: 10.1093/eurheartj/eht232. View

Rego R, Berardo F, Rodrigues S, Oliveira Z, Oliverira M, Vasconcellos C . [Risk factors for chronic non-communicable diseases: a domiciliary survey in the municipality of São Paulo, SP (Brazil). Methodology and preliminary results]. Rev Saude Publica. 1990; 24(4):277-85. DOI: 10.1590/s0034-89101990000400005. View

Lotufo P . Why has the rise in obesity not reversed the decline in cardiovascular mortality? Cardiometabolic death rate trends in Brazil (1980-2011). Sao Paulo Med J. 2015; 133(1):1-3. PMC: 10496623. DOI: 10.1590/1516-3180.2014.1331979. View

Schmidt M, Hoffmann J, Diniz M, Lotufo P, Griep R, Bensenor I . High prevalence of diabetes and intermediate hyperglycemia - The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Diabetol Metab Syndr. 2015; 6:123. PMC: 4363046. DOI: 10.1186/1758-5996-6-123. View

Lotufo P, Bensenor I . Stroke mortality in Brazil: one example of delayed epidemiological cardiovascular transition. Int J Stroke. 2009; 4(1):40-1. DOI: 10.1111/j.1747-4949.2009.00240.x. View

10.

Nicolau J, Franken M, Lotufo P, Carvalho A, Marin Neto J, Lima F . Use of demonstrably effective therapies in the treatment of acute coronary syndromes: comparison between different Brazilian regions. Analysis of the Brazilian Registry on Acute Coronary Syndromes (BRACE). Arq Bras Cardiol. 2012; 98(4):282-9. DOI: 10.1590/s0066-782x2012000400001. View

11.

McGovern P, Jacobs Jr D, Shahar E, Arnett D, Folsom A, Blackburn H . Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation. 2001; 104(1):19-24. DOI: 10.1161/01.cir.104.1.19. View

12.

Lotufo P, Goulart A, Fernandes T, Bensenor I . A reappraisal of stroke mortality trends in Brazil (1979-2009). Int J Stroke. 2012; 8(3):155-63. DOI: 10.1111/j.1747-4949.2011.00757.x. View

13.

Oliveira J, Milech A, Franco L . The prevalence of diabetes in Rio de Janeiro, Brazil. The Cooperative Group for the Study of Diabetes Prevalence in Rio De Janeiro. Diabetes Care. 1996; 19(6):663-6. DOI: 10.2337/diacare.19.6.663. View

14.

Lotufo P, Pereira A, Vasconcellos P, Santos I, Mill J, Bensenor I . Resistant hypertension: risk factors, subclinical atherosclerosis, and comorbidities among adults-the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). J Clin Hypertens (Greenwich). 2014; 17(1):74-80. PMC: 8031839. DOI: 10.1111/jch.12433. View

15.

Lotufo P, Bensenor I . [Race and stroke mortality in Brazil]. Rev Saude Publica. 2014; 47(6):1201-4. PMC: 4206111. DOI: 10.1590/s0034-8910.2013047004890. View

16.

Mottillo S, Filion K, Belisle P, Joseph L, Gervais A, OLoughlin J . Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur Heart J. 2008; 30(6):718-30. DOI: 10.1093/eurheartj/ehn552. View

17.

DAWBER T, Kannel W, REVOTSKIE N, Stokes 3rd J, Kagan A, Gordon T . Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study. Am J Public Health Nations Health. 1959; 49:1349-56. PMC: 1372949. DOI: 10.2105/ajph.49.10.1349. View

18.

. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 385(9963):117-71. PMC: 4340604. DOI: 10.1016/S0140-6736(14)61682-2. View

19.

Rasella D, Harhay M, Pamponet M, Aquino R, Barreto M . Impact of primary health care on mortality from heart and cerebrovascular diseases in Brazil: a nationwide analysis of longitudinal data. BMJ. 2014; 349:g4014. PMC: 4080829. DOI: 10.1136/bmj.g4014. View

20.

Stone N, Robinson J, Lichtenstein A, Merz C, Blum C, Eckel R . 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 63(25 Pt B):2889-934. DOI: 10.1016/j.jacc.2013.11.002. View